12-week daytime eating study for fatty liver in obesity
Part of Hormones & metabolism clinical trials.
This study tests if restricting eating to daytime hours for 12 weeks can reduce liver fat in people with obesity. It aims to help those with fatty liver disease improve their health without medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Body mass index (BMI) between 30 and 49.9
- Age 18 to 65 years old
- Not very active (light exercise less than 1 hour per week) or moderately active (1 to 2 hours per week)
- Weight stable for at least 3 months (no gain or loss over 4 kg)
- Usually eat over more than 12 hours each day
- Own a smartphone with internet and agree to use it for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether changing when you eat (timing your meals) can improve fatty liver disease. You might be eligible if you have a certain body mass index and eat over 14 hours a day.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study looks at how the timing of meals throughout the day affects your metabolism and health. It involves tracking your eating patterns and answering health questions using your phone or computer.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
This trial tests if a diet low in AGEs (harmful compounds in cooked foods) can improve liver function in adults with fatty liver. It may help those who are sedentary and not on other treatments.
This study looks at whether the natural chemicals made by your gut bacteria from the food you eat could affect liver fat and health. If you have MASLD (a fatty liver condition), researchers want to measure these gut-produced substances to better understand the disease.
Hear when a new MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.